2019-2020 TL1 (T32) Pre-doctoral Clinical & Translational Research Training Program Is Now Open to Application

Dear MUSC SPARC Users,

We are excited to announce that the 2019-2020 TL1 (T32) Pre-doctoral Clinical & Translational Research Training Program is now open to application: https://musc.infoready4.com/#competitionDetail/1786657

The corresponding grant service in SPARC (to obtain your SPARC ID and fill out on the application form) can be found by browsing the service catalog under SCTR/Funding Opportunities or search for the key word:

Detailed Information:

OVERVIEW

The NIH-funded pre-doctoral training program is designed to increase the number of well-trained translational researchers and is tailored for PhD and dual degree candidates with a strong interest in pursuing a career in clinical and/or translational research. The TL1 program aims to address pipeline issues by stimulating interest from doctoral students in health- and disease-related disciplines who will become future leaders in clinical and/or translational research. The program will provide early exposure to clinical and translational research methodology through experiential training opportunities, instructive coursework and the application of team science and cutting edge technology. Trainees will have rigorous research experiences and a complementary didactic curriculum.

TL1 trainees pursue research training on a full-time basis, defined by NIH as a minimum of 40 hours per week, devoting 100% time and effort. Appointments are for 12 months with an option for a second year. Trainees may not work outside of their research area.

ELIGIBILITY

Degree Requirements: Students must have received a baccalaureate degree by the appointment start date and be enrolled in a program leading to a PhD or a combined degree program. The TL1 is designed for students with a strong interest in clinical and/or translational research, and who have prior research experience.

Time Commitment: Trainees must commit 100% effort to the TL1 program and their dissertation research – no exceptions, per federal NRSA guidelines. Appointed TL1 Trainees are not allowed to simultaneously hold another appointment or position and must maintain the appointment during the entire award period.

Citizenship Status: At the time of appointment to the training program, selected individuals must be citizens or non-citizen nationals of the United States, or have been lawfully admitted to the United States for permanent residence and have in their possession a Permanent Resident Card (USCIS Form I-551) or other legal verification of such status.

Training Support: Appointment to the TL1 program is for a period of 1 year with the potential for a second year pending satisfactory progress.

Current TL1 trainees: Current trainees are eligible to compete for a second year of support as long as their anticipated graduation date is after June 30, 2020. However, they must submit a current TL1 progress report as part of their application as defined under “Application Documents”.

Trainees from all disciplines (pre-clinical, clinical and translational) are welcome to apply. Individuals from underrepresented groups, from disadvantaged backgrounds, and/or with disabilities are strongly encouraged to apply.

ADDITIONAL INFORMATION

The TL1 (T32) Pre-doctoral Clinical & Translational Research Training Program is open to PhD and MD/PhD candidates with a strong interest in a career in clinical and translational research.
eRA Commons user IDs are required for all TL1 applicants and mentors. Please contact the Office of Research & Sponsored Program sat 843.792.7198. or orsp@musc.edu if you need to obtain an ID.
Please submit all requested documents as PDFs.
You may save the application and return to complete. Once the application is submitted you will not have the ability to edit.

For more information, or if you have any questions, please contact Carissa Hasseler at hasseler@musc.edu.